Result
Motor function · Secondary, pre-specified · Efficacy
Effect as reported: [object Object]
Location in the source: results
Part 2 - AXER-204 - 200 mg: 0.42 (95% CI -1.07 to 1.91)
Study
NCT03989440/brief_summary
human Human · Open label · Uncontrolled · Outside our vocabulary · AIS not reported
Participants actually studied: 52
No dataNothing has been recorded here yet. This is not a zero.
What this result says about which claim
- Contradicts — Intrathecal administration of a soluble Nogo receptor decoy protein does not improve upper extremity motor strength or hand prehension function after spinal cord injury.
SECONDARY · Change in Graded Redefined Assessment of Strength, Sensation and Prehension (GRASSP) Bilateral Prehension Performance Score · unit: score on a scale · measured at: Baseline to Day 169 Part 2 - AXER-204 - 200 mg: 0.42 (95% CI -1.07 to 1.91) Part 2 - Placebo: 1.97 (95% CI 0.41 to 3.54)